NCT04619277 is a clinical trial of drug-coated balloon in Drug-coated Balloon, sponsored by Ulsan Medical Center.

Who is sponsoring NCT04619277?

NCT04619277 is sponsored by Ulsan Medical Center.

What drugs are being tested in NCT04619277?

Interventions in NCT04619277: drug-coated balloon.

What condition does NCT04619277 study?

NCT04619277 studies Drug-coated Balloon.

Is NCT04619277 still recruiting?

NCT04619277 is currently recruiting now. Last updated 15 August 2024.

Last reviewed 2024-08-15 · How we verify

NCT04619277

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Drug-coated Balloon Treatment in de Novo Coronary Lesion

Recruiting now Last updated 15 August 2024

What this trial tests

trial testing drug-coated balloon in Drug-coated Balloon in 10,000 participants. Currently enrolling.

Timeline

22 April 2011

Primary endpoint
31 December 2030

31 December 2030

Quick facts

Lead sponsor	Ulsan Medical Center
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	10,000
Start date	22 April 2011
Primary completion	31 December 2030
Estimated completion	31 December 2030
Sites	1 location across South Korea

Drugs / interventions tested

drug-coated balloon

Conditions studied

Drug-coated Balloon — all drugs for Drug-coated Balloon →

Sponsor

Ulsan Medical Center

Who can join

Eligibility, any sex, with Drug-coated Balloon. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is the international multicenter registry for drug-coated balloon treatment for de novo coronary lesion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of drug-coated balloon

Trials testing the same drug.

NCT07162792 — The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT · NA · not yet recruiting
NCT07014475 — Efficacy of the Ranger Drug-Coated Balloon in Treating BTK Lesions in Patients With CLTI · not yet recruiting
NCT06104033 — Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease · recruiting
NCT05616520 — Treatment of Complex Femoropopliteal Artery Lesions Using Drug-coated PTA Balloon · unknown
NCT05550233 — Drug-coated Balloons in Big de Novo Coronary Disease · NA · unknown

Other recruiting trials for Drug-coated Balloon

Currently open trials in the same condition.

NCT04826705 — A Study of Endovascular Treatment of Femoropopliteal Arterial Occlusive Lesion With Drug-Coated Balloon · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04619277 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ulsan Medical Center
Last refreshed: 15 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04619277.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing